Organoids for the study of pancreatic cancer with David Tuveson
David Tuveson is The Cancer Center Director and the Director of the Cancer Therapeutics Initiative at Cold Spring Harbor Laboratory and the Chief Scientist for the Lustgarten Foundation for Pancreatic Cancer Research(both NY, USA). Here he explores the cell biology techniques for developing disease models of pancreatic cancer enabling further understanding of the condition and the targeting drug discovery.
Submit Your Research to the F1000Research Oncology Gateway
Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.
Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.
